Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis

Drug and Alcohol Dependence

Volumn 90, Issue 2-3, 2007, Pages 159-165

  Glatt, Stephen J ^a   Bousman, Chad ^b   Wang, Richard S ^b   Murthy, Kenton K ^b   Rana, Brinda K ^b   Lasky Su, Jessica A ^a   Zhu, Shao C ^c   Zhang, Ruimin ^d   Li, Jianhua ^d   Zhang, Bo ^d   Li, Jixiang ^d   Lyons, Michael J ^e   Faraone, Stephen V ^a   Tsuang, Ming T ^b,f,g  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d Yunnan Institute of Drug Abuse   (China)

^e BOSTON UNIVERSITY   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Allelic association; Genetic polymorphism; Mu opioid receptor gene; Opiate dependence; Opioid dependence

Indexed keywords

DIAMORPHINE; MU OPIATE RECEPTOR;

ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HEROIN DEPENDENCE; HIGH RISK BEHAVIOR; HUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DNA; GENOTYPE; HEROIN DEPENDENCE; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, OPIOID, MU;

EID: 34548129548     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.02.022     Document Type: Article

References (41)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (1994), American Psychiatric Association, Washington, DC
2. Arias A., Feinn R., and Kranzler H.R. Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. Drug Alcohol Depend. 83 (2006) 262-268
3. Bart G., Heilig M., LaForge K.S., Pollak L., Leal S.M., Ott J., and Kreek M.J. Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol. Psychiatry 9 (2004) 547-549
4. Bart G., Kreek M.J., Ott J., LaForge K.S., Proudnikov D., Pollak L., and Heilig M. Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology 30 (2005) 417-422
5. Bergen A.W., Kokoszka J., Peterson R., Long J.C., Virkkunen M., Linnoila M., and Goldman D. Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol. Psychiatry 2 (1997) 490-494
6. Berrettini W.H., and Lerman C.E. Pharmacotherapy and pharmacogenetics of nicotine dependence. Am. J. Psychiatry 162 (2005) 1441-1451
7. Bond C., LaForge K.S., Tian M., Melia D., Zhang S., Borg L., Gong J., Schluger J., Strong J.A., Leal S.M., Tischfield J.A., Kreek M.J., and Yu L. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proceedings of the National Academy of Sciences of the United States of America, vol. 95 (1998) 9608-9613
8. Chen W.J., Liu S.K., Chang C.J., Lien Y.J., Chang Y.H., and Hwu H.G. Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am. J. Psychiatry 155 (1998) 1214-1220
9. Crowley J.J., Oslin D.W., Patkar A.A., Gottheil E., DeMaria Jr. P.A., O'Brien C.P., Berrettini W.H., and Grice D.E. A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatric Genet. 13 (2003) 169-173
10. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 7 (1986) 177-188
11. Devlin B., Roeder K., and Wasserman L. Genomic control, a new approach to genetic-based association studies. Theor. Popul. Biol. 60 (2001) 155-166
12. Drakenberg K., Nikoshkov A., Horvath M.C., Fagergren P., Gharibyan A., Saarelainen K., Rahman S., Nylander I., Bakalkin G., Rajs J., Keller E., and Hurd Y.L. Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers. Proceedings of the National Academy of Sciences of the United States of America, vol. 103 (2006) 7883-7888
13. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
14. Faraone S.V., Blehar M., Pepple J., Moldin S., Norton J., Tsuang M.T., Nurnberger J.I., Malaspina D., Kaufmann C.A., Reich T., Cloninger C.R., DePaulo J.R., Berg K., Gershon E.S., and Kirch D.G. Diagnostic accuracy and confusability analyses: an application to the diagnostic interview for genetic studies. Psychol. Med. 26 (1996) 401-410
15. Franke P., Wang T., Nothen M.M., Knapp M., Neidt H., Albrecht S., Jahnes E., Propping P., and Maier W. Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence. Am. J. Med. Genet. B Neuropsychiatric Genet. 105 (2001) 114-119
16. Gelernter J., Kranzler H., and Cubells J. Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects. Mol. Psychiatry 4 (1999) 476-483
17. Gelernter J., Panhuysen C., Wilcox M., Hesselbrock V., Rounsaville B., Poling J., Weiss R., Sonne S., Zhao H., Farrer L., and Kranzler H.R. Genomewide linkage scan for opioid dependence and related traits. Am. J. Human Genet. 78 (2006) 759-769
18. Glatt S.J., Su J.A., Zhu S.C., Zhang R., Zhang B., Li J., Yuan X., Lyons M.J., Faraone S.V., and Tsuang M.T. Genome-wide linkage analysis of heroin dependence in Han Chinese: results from wave one of a multi-stage study. Am. J. Med. Genet. B Neuropsychiatric Genet. 141 (2006) 648-652
19. Hernandez-Avila C.A., Wand G., Luo X., Gelernter J., and Kranzler H.R. Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am. J. Med. Genet. B Neuropsychiatric Genet. 118 (2003) 60-65
20. Hernandez-Avila C.A., Covault J., Gelernter J., and Kranzler H.R. Association study of personality factors and the Asn40Asp polymorphism at the mu-opioid receptor gene (OPRM1). Psychiatric Genet. 14 (2004) 89-92
21. Joo E.J., Joo Y.H., Hong J.P., Hwang S., Maeng S.J., Han J.H., Yang B.H., Lee Y.S., and Kim Y.S. Korean version of the diagnostic interview for genetic studies: Validity and reliability. Compr. Psychiatry 45 (2004) 225-229
22. Jorm A.F., Prior M., Sanson A., Smart D., Zhang Y., Tan S., and Easteal S. Lack of association of a single-nucleotide polymorphism of the mu-opioid receptor gene with anxiety-related traits: results from a cross-sectional study of adults and a longitudinal study of children. Am. J. Med. Genet. B Neuropsychiatric Genet. 114 (2002) 659-664
23. Kendler K.S., Karkowski L.M., Neale M.C., and Prescott C.A. Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch. Gen. Psychiatry 57 (2000) 261-269
24. Lange C., DeMeo D., Silverman E.K., Weiss S.T., and Laird N.M. PBAT: tools for family-based association studies. Am. J. Human Genet. 74 (2004) 367-369
25. Lerman C., Wileyto E.P., Patterson F., Rukstalis M., Audrain-McGovern J., Restine S., Shields P.G., Kaufmann V., Redden D., Benowitz N., and Berrettini W.H. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Pharmacogenomics J. 4 (2004) 184-192
26. Li T., Liu X., Zhu Z., Zhao J., Hu X., Sham P., and Collier D. Association analysis of polymorphisms in the mu opioid gene and heroin abuse in Chinese. Addict. Biol. 5 (2000) 181-186
27. Luo X., Kranzler H.R., Zhao H., and Gelernter J. Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans. Am. J. Med. Genet. B Neuropsychiatric Genet. 120 (2003) 97-108
28. Nurnberger Jr. J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., Severe J.B., Malaspina D., Reich T., Miller M., Bowman E.S., DePaulo J.R., Cloninger C.R., Robinson G., Moldin S., Gershon E.S., Maxwell E., Guroff J.J., Kirch D., Wynne D., Berg K., Tsuang M.T., Faraone S.V., Pepple J.R., and Ritz A.L. Diagnostic interview for genetic studies. Rationale, unique features, and training. Arch. Gen. Psychiatry 51 (1994) 849-859
29. Oslin D.W., Berrettini W., Kranzler H.R., Pettinati H., Gelernter J., Volpicelli J.R., and O'Brien C.P. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28 (2003) 1546-1552
30. Palacio C.A., Garcia J., Arbelaez M.P., Sanchez R., Aguirre B., Garces I.C., Montoya G.J., Gomez J., Agudelo A., Lopez C.A., Calle J.J., Cardeno C.A., Cano J.F., Lopez M.C., Montoya P., Herrera C.P., Gonzalez N., Gonzalez A., Bedoya G., Ruiz A., and Ospina J. Validation of the Diagnostic Interview for Genetic Studies (DIGS) in Colombia. Biomedica 24 (2004) 56-62
31. Preisig M., Fenton B.T., Matthey M.L., Berney A., and Ferrero F. Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of the French version. Euro. Arch. Psychiatry Clin. Neurosci. 249 (1999) 174-179
32. Shi J., Hui L., Xu Y., Wang F., Huang W., and Hu G. Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Hum. Mutat. 19 (2002) 459-460
33. Szeto C.Y., Tang N.L., Lee D.T., and Stadlin A. Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts. Neuroreport 12 (2001) 1103-1106
34. Tan E.C., Tan C.H., Karupathivan U., and Yap E.P. Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport 14 (2003) 569-572
35. Town T., Schinka J., Tan J., and Mullan M. The opioid receptor system and alcoholism: a genetic perspective. Euro. J. Pharmacol. 410 (2000) 243-248
36. Tsuang M.T., Lyons M.J., Eisen S.A., Goldberg J., True W., Lin N., Meyer J.M., Toomey R., Faraone S.V., and Eaves L. Genetic influences on DSM-III-R drug abuse and dependence: A study of 3,372 twin pairs. Am. J. Med. Genet. (Neuropsychiatric Genet.) 67 (1996) 473-477
37. Tsuang M.T., Lyons M.J., Meyer J.M., Doyle T., Eisen S.A., Goldberg J., True W., Lin N., Toomey R., and Eaves L. Co-occurrence of abuse of different drugs in men. The role of drug-specific and shared vulnerabilities. Arch. Gen. Psychiatry 55 (1998) 967-972
38. Van Den Bree M.B., Johnson E.O., Neale M.C., and Pickens R.W. Genetic and environmental influences on drug use and abuse/dependence in male and female twins. Drug Alcohol Depend. 52 (1998) 231-241
39. Woolf B. On estimating the relation between blood group and disease. Annu. Eugenics 19 (1955) 251-253
40. Zhang H., Luo X., Kranzler H.R., Lappalainen J., Yang B.Z., Krupitsky E., Zvartau E., and Gelernter J. Association between two {micro}-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum. Mol. Genet. 15 (2006) 807-819
41. Zhang L., Kendler K.S., and Chen X. The mu-opioid receptor gene and smoking initiation and nicotine dependence. Behav. Brain Funct. 2 (2006) 28